Skip to main content

Table 1 Patient characteristics in the control and PostC groups

From: Long-term impact of postconditioning on infarct size and left ventricular ejection fraction in patients with ST-elevation myocardial infarction

Variables Control group PostC group p
  n = 35 n = 33  
At admission    
 Age, years (range) 62 (42–85) 63 (37–85) 0.96
 Male sex 31 (89) 28 (85) 0.73
 Body mass index, kg/m2 (IQR) 27 (25, 29) 27 (25, 31) 0.37
 Ischemia time, minutes (IQR) 180 (141, 255) 165 (133, 202) 0.27
 Current smokers 9 (26) 9 (27) 1.0
 Hypertension 11(31) 5(15) 0.16
 Previous angina 3 (9) 5 (15) 0.47
 Diabetes mellitus* 10 (32) 9 (29) 1.0
Treatment on admission    
 Aspirin, 3 (9) 1 (3) 0.61
 Beta-blockers 4 (11) 1 (3) 0.36
 ACE/ARB 6 (17) 2 (6) 0.26
 Statins 3 (9) 2 (6) 1.0
Treatment during angioplasty    
 Aspirin 35 (100) 31 (94) 0.23
 Clopidogrel 34 (97) 31 (94) 0.61
 Glycoprotein inhibitors 27 (77) 26 (79) 1.0
 Opioids 26 (74) 28 (85) 0.37
Treatment at discharge    
 Aspirin, n (%) 35 (100) 32 (97) 0.49
 Clopidogrel, n (%) 35 (100) 33 (100) 1.0
 Beta-blockers, n (%) 34 (97) 33 (100) 1.0
 ACE/ARB, n (%) 20 (57) 21 (61) 0.64
 Statins, n (%) 34 (97) 32 (97) 1.0
  1. Data are presented as median and quartiles for continuous variables except age which is median and range, or number of patients and percentage for dichotomous variables. ACE Angiotensin converting enzyme inhibitor; ARB Angiotensin receptor blocker. * n = 31 both in Control and PostC.